Aquestive Therapeutics, Inc. · NASDAQ:AQST

BRATTON DOUGLAS K's stake in Aquestive Therapeutics, Inc. fell to 0.60% (Schedule 13G/A)

Event Oct 7, 2026 · Filed Oct 7, 2026

BRATTON DOUGLAS K's stake in Aquestive Therapeutics, Inc. fell to 0.60%, 691,873 shares, as a passive investor on Oct 7, 2026. Filed Oct 7, 2026 (Schedule 13G/A).

Stake
0.60%
Shares
691,873
Intent
Passive
What changed
Fell below 5%
Filed together
9 holders

The filing in full

HolderStakeShares
BRATTON DOUGLAS K0.60%691,873
MonoLine RX II, L.P.0%0
MonoLine RX III, L.P.0%0
MonoLine RX, L.P.0%0
MonoLine Partners, L.P.0%0
MonoSol Rx Genpar, L.P.0%0
Bratton Capital Management, L.P.0.30%390,795
Bratton Capital Inc.0.30%391,670
Bratton Family Partners L.P.0%33,727

Source

View original at SEC

Related